| Rank | Title | Journal | Year | PubWeight™‹?› |
|---|---|---|---|---|
| 1 | The effect of dipeptidyl peptidase-IV inhibition on bone in a mouse model of type 2 diabetes. | Diabetes Metab Res Rev | 2014 | 1.45 |
| 2 | Quality of life in sarcopenia and frailty. | Calcif Tissue Int | 2013 | 1.17 |
| 3 | Type 2 diabetic mice demonstrate slender long bones with increased fragility secondary to increased osteoclastogenesis. | Bone | 2008 | 1.03 |
| 4 | Once-monthly oral ibandronate compared with weekly oral alendronate in postmenopausal osteoporosis: results from the head-to-head MOTION study. | Curr Med Res Opin | 2008 | 0.96 |
| 5 | Diabetes and fragility fractures - a burgeoning epidemic? | Bone | 2008 | 0.88 |
| 6 | Questioning the association between bisphosphonates and atypical femoral fractures. | Ann N Y Acad Sci | 2014 | 0.75 |
| 7 | Osteoporosis. Preface. | Endocrinol Metab Clin North Am | 2012 | 0.75 |
| 8 | The importance of vitamin D. Preface. | Endocrinol Metab Clin North Am | 2010 | 0.75 |